These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 34765598)

  • 21. Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    Toyokawa T; Muguruma K; Yoshii M; Tamura T; Sakurai K; Kubo N; Tanaka H; Lee S; Yashiro M; Ohira M
    BMC Cancer; 2020 Jun; 20(1):517. PubMed ID: 32493247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma.
    Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M
    Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative Serum Hypersensitive-c-Reactive-Protein (Hs-CRP) to Albumin Ratio Predicts Survival in Patients with Luminal B Subtype Breast Cancer.
    Liu X; Guo X; Zhang Z
    Onco Targets Ther; 2021; 14():4137-4148. PubMed ID: 34276217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological Features Combined With Immune Infiltration Could Well Distinguish Outcomes in Stage II and Stage III Colorectal Cancer: A Retrospective Study.
    Ren J; Xu L; Zhou S; Ouyang J; You W; Sheng N; Yan L; Peng D; Xie L; Wang Z
    Front Oncol; 2021; 11():776997. PubMed ID: 34926285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prognostic Significance of C-Reactive Protein to Albumin Ratio in Newly Diagnosed Acute Myeloid Leukaemia Patients.
    Dou L; Shi M; Song J; Niu X; Niu J; Wei S; Li D; Bai Y; Sun K
    Cancer Manag Res; 2022; 14():303-316. PubMed ID: 35115829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma.
    Xu XL; Yu HQ; Hu W; Song Q; Mao WM
    PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
    Matsubara T; Takamori S; Haratake N; Fujishita T; Toyozawa R; Ito K; Shimokawa M; Yamaguchi M; Seto T; Okamoto T
    Ann Surg Oncol; 2021 Jun; 28(6):3046-3054. PubMed ID: 33084992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery.
    Kawashima M; Murakawa T; Shinozaki T; Ichinose J; Hino H; Konoeda C; Tsuchiya T; Murayama T; Nagayama K; Nitadori J; Anraku M; Nakajima J
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):637-43. PubMed ID: 26269495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Serum CYFRA 21-1 in Diagnosis and Prognostic in Colorectal Liver Metastases.
    Li S; Wei W; Feng Z; Bian Y; Pan J; Mai J; Ning S; Huang J; Gao X; Zhang L
    Cancer Manag Res; 2023; 15():601-614. PubMed ID: 37434913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study.
    Guo Y; Cai K; Mao S; Zhang J; Wang L; Zhang Z; Liu M; Zhang W; Wu Y; Yan Y; Yao X
    Cancer Manag Res; 2018; 10():4789-4804. PubMed ID: 30425573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
    Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative C-Reactive Protein/Albumin Ratio is a Prognostic Indicator for Survival in Surgically Treated Gastrointestinal Stromal Tumors: A Retrospective Cohort Study.
    Cao X; Cui J; Li Z; Zhao G
    Cancer Manag Res; 2021; 13():4155-4167. PubMed ID: 34079369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Glasgow prognostic score is valuable for colorectal cancer with both synchronous and metachronous unresectable liver metastases.
    Furukawa K; Shiba H; Haruki K; Fujiwara Y; Iida T; Mitsuyama Y; Ogawa M; Ishida Y; Misawa T; Yanaga K
    Oncol Lett; 2012 Aug; 4(2):324-328. PubMed ID: 22844378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma.
    Zheng C; Liu S; Feng J; Zhao X
    Cancer Manag Res; 2020; 12():2415-2425. PubMed ID: 32280277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of preoperative D-dimer to albumin ratio for overall survival and progression-free survival in colorectal cancer.
    Wei L; Xie H; Wang Q; Tang S; Gan J
    Front Physiol; 2024; 15():1369855. PubMed ID: 38487266
    [No Abstract]   [Full Text] [Related]  

  • 37. Prognostic role and clinical significance of C-reactive protein-lymphocyte ratio in colorectal cancer.
    Meng Y; Long C; Huang X; Huang L; Liao L; Tang W; Liu J
    Bioengineered; 2021 Dec; 12(1):5138-5148. PubMed ID: 34436973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
    He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
    Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The C-Reactive Protein to Albumin Ratio as a Predictor of Severe Side Effects of Adjuvant Chemotherapy in Stage III Colorectal Cancer Patients.
    Tominaga T; Nonaka T; Sumida Y; Hidaka S; Sawai T; Nagayasu T
    PLoS One; 2016; 11(12):e0167967. PubMed ID: 27930703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.